October 17, 2016

UWSOP Alumnus Watanabe named National Academy of Medicine Fellow

Jonathan H. Watanabe, PharmD, PhD

Jonathan H. Watanabe, PharmD, PhD

University of Washington School of Pharmacy alumnus, Jonathan H. Watanabe, PharmD, Ph.D., ’08, ’12, has been selected as one of three outstanding health professionals for the class of 2016 Fellows National Academy of Medicine (NAM).

The NAM fellows were chosen based on their professional qualifications, reputations as scholars, professional accomplishments, and relevance of current field expertise to the work of the NAM and the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine. There is only one pharmacy fellow nationally.

Watanabe earned both a master’s and doctoral degree in UW School of Pharmacy’s Pharmaceutical Outcomes Research and Policy Program, after earning his undergraduate degree at the UW. He was the first recipient of the prestigious UW/Allergan Post-doctoral Fellowship in Health Economics and Outcomes Research. His major research areas include: cost time to-event analysis, cost epidemiologic assessments, payer cost modeling, drug interactions impact, guidelines adherence assessment, and is interested in biostatistical methods (survival analysis) and applications of epidemiologic techniques to cost analysis.

The Class of 2016 NAM Fellows include: Pharmacy Fellow Jonathan H. Watanabe, PharmD, Ph.D., assistant professor of clinical pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego; Osteopathic Medicine Fellow Jennie H. Kwon, DO, Washington University School of Medicine; and James C. Puffer, M.D./American Board of Family Medicine (ABFM) Fellow Sean C. Lucan, MD, MPH, M.S., Albert Einstein College of Medicine, Bronx, N.Y.
The fellows will collaborate with eminent researchers, policy experts, and clinicians from across the country. They will help facilitate initiatives convened by the Academies to provide nonpartisan, evidence-based guidance to national, state, and local policymakers, academic leaders, health care administrators, and the public.

Each fellow will continue in his or her primary academic post while engaging part time over a two-year period in the Academies’ health and science policy work. Each will work with an expert study committee or roundtable related to his or her professional interests, including contributing to its reports or other products. A flexible research stipend of $25,000 will be awarded to every fellow.

Advance your career in patient-centered outcomes research at the University of Washington. Learn more about our Graduate Programs in Pharmaceutical Outcomes Research and Policy.


Link to Department of Pharmacy archived news